Norito Katoh

9.3k total citations · 3 hit papers
263 papers, 5.1k citations indexed

About

Norito Katoh is a scholar working on Dermatology, Immunology and Allergy and Physiology. According to data from OpenAlex, Norito Katoh has authored 263 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Dermatology, 77 papers in Immunology and Allergy and 63 papers in Physiology. Recurrent topics in Norito Katoh's work include Dermatology and Skin Diseases (117 papers), Allergic Rhinitis and Sensitization (62 papers) and Asthma and respiratory diseases (55 papers). Norito Katoh is often cited by papers focused on Dermatology and Skin Diseases (117 papers), Allergic Rhinitis and Sensitization (62 papers) and Asthma and respiratory diseases (55 papers). Norito Katoh collaborates with scholars based in Japan, United States and Germany. Norito Katoh's co-authors include Saburo Kishimoto, Risa Tamagawa‐Mineoka, Hideya Takenaka, Jun Asai, Hirokazu Yasuno, Koji Masuda, Thomas Bieber, Shinya Hirano, Koji Masuda and Eiichiro Ueda and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Norito Katoh

245 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

2021 350 citations Emma Guttman‐Yassky, Henrique D. Teixeira et al. profile →
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial

2022 134 citations Kristian Reich, Jacob P. Thyssen et al. profile →
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis

2022 122 citations Eric L. Simpson, Kim Papp et al. profile →

Peers

Countries citing papers authored by Norito Katoh

Since Specialization

Citations

This map shows the geographic impact of Norito Katoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norito Katoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norito Katoh more than expected).

Fields of papers citing papers by Norito Katoh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norito Katoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norito Katoh. The network helps show where Norito Katoh may publish in the future.

Co-authorship network of co-authors of Norito Katoh

This figure shows the co-authorship network connecting the top 25 collaborators of Norito Katoh. A scholar is included among the top collaborators of Norito Katoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norito Katoh. Norito Katoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis 2025 ·Dermatology and Therapy ·Eric L. Simpson, Jonathan I. Silverberg, Vimal H. Prajapati, Kilian Eyerich, Norito Katoh, Mark Boguniewicz, Emma Guttman‐Yassky, (unknown), Wan‐Ju Lee, Henrique D. Teixeira, Tianshuang Wu, (unknown), (unknown), Brian Calimlim, Marjolein de Bruin‐Weller	1
2	A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b Study 2025 ·Dermatology and Therapy ·Adam Reich, Andrew Blauvelt, Stephan Weidinger, Vivian Y. Shi, Norito Katoh, Charles Lynde, Xing‐Hua Gao, Nicole M. Armstrong, Charlotte Bernigaud, (unknown)	0
3	Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years 2025 ·Journal of the European Academy of Dermatology and Venereology ·Christopher G. Bunick, Alan D. Irvine, Jonathan I. Silverberg, Emma Guttman‐Yassky, Mona Shahriari, Xing‐Hua Gao, Stephan Weidinger, Norito Katoh, (unknown), (unknown), Elvira D’Andrea, Henrique D. Teixeira, (unknown), (unknown)	0
4	Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of eight clinical trials 2025 ·British Journal of Dermatology ·Kristian Reich, Richard G. Langley, J.F. Silvestre, D. Staumont‐Sallé, Antonio Costanzo, Andrew Pink, Amy S. Paller, Norito Katoh, Andreas Wollenberg, Richard B. Warren, Andrew Blauvelt, (unknown), (unknown), Le Gjerum, Eric L. Simpson	0
5	1477P Overall survival among 4913 patients with hepatocellular carcinoma treated with external beam radiation therapy: Individual patient data outcomes from a multinational cohort 2025 ·Annals of Oncology ·María Reig, Andrew M. Moon, Ted K. Yanagihara, Laura A. Dawson, (unknown), Theodore S. Lawrence, Tae Hyun Kim, Michael Yan, Hiromitsu Iwata, Nima Nabavizadeh, Smith Apisarnthanarax, (unknown), M.T.W.T. Lock, Michael D. Chuong, (unknown), Marta Scorsetti, Norito Katoh, (unknown), Kazushi Numata, Ferràn Torres	1
6	Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients with Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials 2024 ·SKIN The Journal of Cutaneous Medicine ·Kristian Reich, Richard G. Langley, (unknown), D. Staumont‐Sallé, Antonio Costanzo, Andrew Pink, Amy S. Paller, Norito Katoh, Andreas Wollenberg, Richard B. Warren, (unknown), (unknown), Le Gjerum, Eric L. Simpson	2
7	English version of Japanese guidance for biologics in treating atopic dermatitis 2023 ·The Journal of Dermatology ·Hidehisa Saeki, Masashi Akiyama, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukihiro Ohya, Norito Katoh, Hideto Kameda, Kenji Kabashima, Yuichiro Tsunemi, Michihiro Hide, Mamitaro Ohtsuki	6
8	Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials 2023 ·American Journal of Clinical Dermatology ·Eric L. Simpson, Andrew Pink, Andrew Blauvelt, Melinda Gooderham, April W. Armstrong, Margitta Worm, Norito Katoh, Ketty Peris, L. Puig, S. Barbarot, (unknown), Louise Abildgaard Steffensen, (unknown), Andreas Wollenberg	15
9	Abrocitinib effect on patient‐reported outcomes in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study 2023 ·Journal of the European Academy of Dermatology and Venereology ·Kristian Reich, Jonathan I. Silverberg, Kim Papp, Mette Deleuran, Norito Katoh, Bruce Strober, Lisa A. Beck, Marjolein de Bruin‐Weller, Thomas Werfel, (unknown), (unknown), Marco DiBonaventura, Gary Chan, (unknown), (unknown), Claire Clibborn	5
10	Abrocitinib efficacy and safety in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study 2023 ·Journal of the European Academy of Dermatology and Venereology ·Kristian Reich, Jonathan I. Silverberg, Kim Papp, Mette Deleuran, Norito Katoh, Bruce Strober, Lisa A. Beck, Marjolein de Bruin‐Weller, Thomas Werfel, Fan Zhang, Pinaki Biswas, Marco DiBonaventura, Gary Chan, Susan Johnson, (unknown), Urs Kerkmann, Claire Clibborn	20
11	Efficacy of dupilumab in moderate and severe atopic dermatitis 2023 ·SHILAP Revista de lepidopterología ·Stephan Weidinger, Eric L. Simpson, Jonathan I. Silverberg, Jochen Schmitt, Yael A. Leshem, Norito Katoh, Zhen Chen, Haixin Zhang, Brad Shumel, Ashish Bansal, Jingdong Chao, Yufang Lü, Ana B. Rossi, (unknown)	2
12	Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials 2022 ·Journal of Dermatological Treatment ·Thomas Bieber, Norito Katoh, Eric L. Simpson, Marjolein de Bruin‐Weller, Diamant Thaçi, Antonio Torrelo, (unknown), Susanne Grond, Maher Issa, Xiaoyu Lu, Tracy Cardillo, Katrin Holzwarth, Jacob P. Thyssen	32
13	Efficacy and safety of apremilast and phototherapy versus phototherapy only in psoriasis vulgaris 2022 ·The Journal of Dermatology ·Akimichi Morita, Yukie Yamaguchi, Chiharu Tateishi, (unknown), (unknown), (unknown), Daisuke Hayashi, Y. Watanabe, Yuko Watanabe, (unknown), Koji Masuda, Daisuke Tsuruta, Norito Katoh	5
14	Clinical Usefulness of the Platelet-to Lymphocyte Ratio in Patients with Angiosarcoma of the Face and Scalp 2017 ·International Journal of Molecular Sciences ·Gen Suzuki, Hideya Yamazaki, Norihiro Aibe, Koji Masui, Naomi Sasaki, Daisuke Shimizu, (unknown), Jun Asai, Makoto Wada, (unknown), Norito Katoh, Kei Yamada	13
15	Novel mutations in SLC30A2 involved in the pathogenesis of transient neonatal zinc deficiency 2016 ·Pediatric Research ·Naoya Itsumura, (unknown), Kazuhisa Fukue, (unknown), Kenji Fukushima, Risa Tamagawa‐Mineoka, Norito Katoh, Yukina Nishito, (unknown), Hiroshi Narita, Hiroko Kodama, Taiho Kambe	34
16	Atopic Dermatitis, Dry Skin and Serum IgE in Children in a Community in Japan 2008 ·Dermatitis ·(unknown), Norito Katoh, Shinya Hirano, Saburo Kishimoto, Kotaro Ozasa	1
17	Effect of Maxacalcitol on Psoriasis Vulgaris-A Comparative Study of Maxacalcitol Ointment and High-concentration Tacalcitol Ointment- 2006 ·The Nishinihon Journal of Dermatology ·Norito Katoh, Saburo Kishimoto	1
18	Study on the reliability and reproducibility of visual assessment for human skin irritation test 2003 ·Keiichi Kawai, Isao Yoshimura, (unknown), M. Nakagawa, Kayoko Suzuki, (unknown), Norito Katoh, Hiroshi Itagaki, (unknown), Hajime Kojima, Kayoko Matsunaga, (unknown), Masatoshi Itoh	1
19	Engagement of FcεRI on Human Monocytes Induces the Production of IL-10 and Prevents Their Differentiation in Dendritic Cells 2001 ·The Journal of Immunology ·Natalija Novak, Thomas Bieber, Norito Katoh	94
20	A Malignant Proliferating Trichilemmal Cyst with a Large Cyst. 1991 ·The Nishinihon Journal of Dermatology ·Norito Katoh, Keisuke Konishi, Kazuo Kobayashi, (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact